Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan E Bilsland

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncogenesis|April 26, 2013
MicroRNA and senescence: the senectome, integration and distributed controlAlan E Bilsland, John Revie, W Keith
RSC Medicinal Chemistry|November 2, 2022
Implementation of an AI-assisted fragment-generator in an open-source platformAlan E Bilsland, Angelo Pugliese, Justin Bower
Neoplasia (New York, N.Y.)|December 8, 2005
Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapyAlan E Bilsland, Aileen Fletcher-Monaghan, W Nicol Keith
F1000Research|September 17, 2016
Virotherapy: cancer gene therapy at last?Alan E Bilsland, Pavlina Spiliopoulou, T R Jeffry Evans
Journal of Cellular and Molecular Medicine|January 5, 2011
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectivesAlan E Bilsland, Claire J Cairney, W Nicol Keith
Cancer Research|February 7, 2007
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenovirusesAlan E Bilsland, Andrew Merron, Georges Vassaux, et al.
Journal of Chemical Information and Modeling|May 24, 2021
Automated Generation of Novel Fragments Using Screening Data, a Dual SMILES Autoencoder, Transfer Learning and Syntax CorrectionAlan E Bilsland, Kirsten McAulay, Ryan West, et al.
Cancer Research|February 3, 2006
Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3Alan E Bilsland, Katrina Stevenson, Stuart Atkinson, et al.
Plos Computational Biology|February 20, 2014
Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanismsAlan E Bilsland, Katrina Stevenson, Yu Liu, et al.
Drug Discovery Today|February 9, 2012
Cancer cell senescence: a new frontier in drug developmentClaire J Cairney, Alan E Bilsland, T R Jeffry Evans, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncogenesis|April 26, 2013
MicroRNA and senescence: the senectome, integration and distributed controlAlan E Bilsland, John Revie, W Keith
RSC Medicinal Chemistry|November 2, 2022
Implementation of an AI-assisted fragment-generator in an open-source platformAlan E Bilsland, Angelo Pugliese, Justin Bower
Neoplasia (New York, N.Y.)|December 8, 2005
Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapyAlan E Bilsland, Aileen Fletcher-Monaghan, W Nicol Keith
F1000Research|September 17, 2016
Virotherapy: cancer gene therapy at last?Alan E Bilsland, Pavlina Spiliopoulou, T R Jeffry Evans
Journal of Cellular and Molecular Medicine|January 5, 2011
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectivesAlan E Bilsland, Claire J Cairney, W Nicol Keith
Cancer Research|February 7, 2007
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenovirusesAlan E Bilsland, Andrew Merron, Georges Vassaux, et al.
Journal of Chemical Information and Modeling|May 24, 2021
Automated Generation of Novel Fragments Using Screening Data, a Dual SMILES Autoencoder, Transfer Learning and Syntax CorrectionAlan E Bilsland, Kirsten McAulay, Ryan West, et al.
Cancer Research|February 3, 2006
Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3Alan E Bilsland, Katrina Stevenson, Stuart Atkinson, et al.
Plos Computational Biology|February 20, 2014
Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanismsAlan E Bilsland, Katrina Stevenson, Yu Liu, et al.
Drug Discovery Today|February 9, 2012
Cancer cell senescence: a new frontier in drug developmentClaire J Cairney, Alan E Bilsland, T R Jeffry Evans, et al.
Pageof 2